Clinical trial
Indole-3-Carbinol in Preventing Cancer in Healthy Participants
NCT00100958 · University of Kansas, Other · Completed
Key facts
| NCT number | NCT00100958 |
|---|---|
| Title | Indole-3-Carbinol in Preventing Cancer in Healthy Participants |
| Official title | Phase I Ascending Single Dose Pharmacokinetics (PK) and Safety Study of 3,3' Di-Indolymethane (DIM) Nutritional Product |
| Lead sponsor | University of Kansas, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | indole-3-carbinol |
| Start date | Nov 1, 2004 |
| First posted | Jan 10, 2005 |
| Last update posted | Jul 24, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: